Peer-influenced content. Sources you trust. No registration required. This is HCN.

Hematology AdvisorNovel Approaches for Monitoring Multiple Myeloma Using cfDNA, Circulating Plasma Cells

According to the results of a study published in Annals of Hematology, two novel analytical approaches for detecting malignant plasma cell clones appear to accurately indicate the course of multiple myeloma (MM) and may be valuable for monitoring patients with serologically nontrackable disease.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form